Clinical Trials Browser

Not yet recruiting × OTHER × Melanoma × Clear all

NCT07527325 2026-04-14

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

Phase 2 Not yet recruiting

Melanoma

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Phase NA Not yet recruiting

DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT07517653 2026-04-08

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Phase 2 Not yet recruiting

Melanoma

NCT07511036 2026-04-06

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

Phase 2 Not yet recruiting

Melanoma

NCT07504796 2026-04-01

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Not yet recruiting

Melanoma

NCT07501104 2026-03-30

TRIUMPH-AM

Phase 2 Not yet recruiting

Melanoma

NCT07492121 2026-03-25

GAPIMET

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT07237594 2026-03-11

REPLAY

Phase 1 Not yet recruiting

Melanoma

NCT07442292 2026-03-05

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Not yet recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

NCT07280715 2026-03-03

IRIS

Phase NA Not yet recruiting

Melanoma, Neoplasms

NCT07444606 2026-03-03

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

Phase 1 Not yet recruiting

Melanoma

NCT07437300 2026-02-27

FIBIOME

Not yet recruiting

Melanoma

NCT07406087 2026-02-25

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Phase NA Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Phase EARLY_PHASE1 Not yet recruiting

DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07376512 2026-01-29

EVpredict

Not yet recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07354152 2026-01-21

COPERGRAM1

Not yet recruiting

Melanoma

NCT07340619 2026-01-14

EPIBREAST

Phase 2 Not yet recruiting

Melanoma, Neoplasm Metastasis

NCT07320222 2026-01-06

CARE-Melanoma

Phase 1 Not yet recruiting

Melanoma

NCT07102212 2025-12-24

FOCUS

Phase NA Not yet recruiting

BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT07293598 2025-12-19

ROTATE

Not yet recruiting

Melanoma

NCT06897735 2025-11-18

EDDIS-a1

Phase 1 Not yet recruiting

DermatologicHead & NeckThoracic

Lung Neoplasms, Melanoma, Mouth Neoplasms

NCT07114172 2025-08-11

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Phase NA Not yet recruiting

Melanoma

NCT07092410 2025-07-29

SuRage-EB

Phase 4 Not yet recruiting

Melanoma

NCT07028008 2025-06-26

Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors

Phase NA Not yet recruiting

Melanoma

NCT06976021 2025-05-16

INTROSPECTION

Phase 2 Not yet recruiting

BreastDermatologicGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Triple Negative Breast Neoplasms

NCT06896552 2025-03-26

Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

Phase 1/2 Not yet recruiting

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasms

NCT06756295 2025-03-12

FAST-CR

Phase EARLY_PHASE1 Not yet recruiting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06785974 2025-01-22

SPIRAL

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

NCT06780397 2025-01-17

Mel-Immuno-Reu

Not yet recruiting

Melanoma

NCT06710093 2024-11-29

PerceIVe

Not yet recruiting

Melanoma

NCT06683755 2024-11-12

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

Phase 1/2 Not yet recruiting

Melanoma

NCT06661577 2024-10-28

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Not yet recruiting

Carcinoma, Basal Cell, Melanoma, Nevus, Skin Neoplasms

NCT06566404 2024-09-23

CORRESPOND

Not yet recruiting

Melanoma

NCT06553781 2024-08-14

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

Phase NA Not yet recruiting

Melanoma

NCT06414343 2024-06-25

LATENT

Not yet recruiting

Melanoma

NCT06470880 2024-06-24

DyNAMIc

Phase 2 Not yet recruiting

Melanoma

NCT05004792 2024-06-17

DAHT-RCT

Phase NA Not yet recruiting

Melanoma

NCT06424626 2024-05-22

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

Phase 1 Not yet recruiting

Melanoma

NCT06327698 2024-03-25

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Phase 2 Not yet recruiting

Melanoma

NCT06212388 2024-01-25

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Phase EARLY_PHASE1 Not yet recruiting

Melanoma

NCT05539118 2022-09-14

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

Phase 1/2 Not yet recruiting

Melanoma

NCT04477876 2020-07-20

NKCD160MEL

Not yet recruiting

Melanoma

NCT02498756 2015-07-15

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Phase 2 Not yet recruiting

Melanoma